Biblio

Author Title [ Type

] Year

Filters: Author is Siahmansouri, Homayoon [Clear All Filters]

Journal Article

Ahmadi M, Abdolmohamadi-Vahid S, Ghaebi M, Dolati S, Abbaspour-Aghdam S, Danaii S, Berjis K, Madadi-Javid R, Nouri Z, Siahmansouri H, et al. Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial. Int Immunopharmacol. 2019;74:105730.

Amin AH, Sharifi LMohammed A, Kakhharov AJamoliddin, Opulencia MJade Catal, Alsaikhan F, Bokov DOlegovich, Majdi HSh, Jawad MAbed, Hammid AThaeer, Shalaby MNader, et al. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival. Biomed Pharmacother. 2022;150:113009.

Dauletova M, Hafsan H, Mahhengam N, Zekiy AOlegovna, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol. 2021:108712.

Huldani H, Jasim SAbdalkaree, Sergeenva KNataliya, Bokov DOlegovich, Abdelbasset WKamal, Turakulov R, Al-Gazally ME, Ahmadzadeh B, Jawhar ZHassan, Siahmansouri H. Mechanisms of cancer stem cells drug resistance and the pivotal role of HMGA2. Pathol Res Pract. 2022;234:153906.

Pourmoghadam Z, Soltani-Zangbar MSadegh, Sheikhansari G, Azizi R, Eghbal-Fard S, Mohammadi H, Siahmansouri H, Aghebati-Maleki L, Danaii S, Mehdizadeh A, et al. Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study. J Reprod Immunol. 2020;142:103182.

Suksatan W, Chupradit S, Yumashev AValerievic, Ravali S, Shalaby MNader, Mustafa YFakri, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol. 2021;101(Pt B):108217.